Pharmabiz2h
DCO India suggests ways to improve functioning of Manipur drug control administration
DCO India suggests ways to improve functioning of Manipur drug control administration: Peethaambaran Kunnathoor, Chennai ...
Pharmabiz2m
US FDA grants marketing authorization of first home test for Chlamydia, gonorrhoea and trichomoniasis
The US Food and Drug Administration (FDA) granted marketing authorization to Visby Medical for the Visby Medical Women’s Sexual Health Test. This is the first diagnostic test for chlamydia, gonorrhoea ...
Pharmabiz1h
US FDA approves Sanofi’s Qfitlia to treat haemophilia A or B, with or without factor inhibitors
Silver Spring, Maryland Monday, March 31, 2025, 09:00 Hrs [IST] ...
Pharmabiz2h
Panel questions efficacy of SPI scheme with limited number of approvals
Panel questions efficacy of SPI scheme with limited number of approvals: Gireesh Babu, New Delhi Monday, March 31, 2025, 08:00 Hrs [IST] The Parliamentary Panel on Chemicals and F ...
Pharmabiz2h
Exporters decry complete withdrawal of RoDTEP scheme for AA products, seek urgent review
Exporters decry complete withdrawal of RoDTEP scheme for AA products, seek urgent review: Shardul Nautiyal, Mumbai Monday, March 31, 2025, 08:00 Hrs [IST] The government’s recen ...
Pharmabiz2h
MSME exporters urge govt to extend interest equalisation scheme amid economic uncertainty
MSME exporters urge govt to extend interest equalisation scheme amid economic uncertainty: Shardul Nautiyal, Mumbai Monday, March 31, 2025, 08:00 Hrs [IST] In a strong appeal to t ...
Pharmabiz2h
Panel recommends more provisions in trade agreements to improve pharma exports
Panel recommends more provisions in trade agreements to improve pharma exports: Gireesh Babu, New Delhi Monday, March 31, 2025, 08:00 Hrs [IST] A Parliamentary Panel on Commerce h ...
Pharmabiz1d
DORC’s ILM-Blue receives China NMPA approval; expanding global reach to prove high-quality and effective solutions to ophthalmic community
DORC’s ILM-Blue receives China NMPA approval; expanding global reach to prove high-quality and effective solutions to ophthalmic community: Jena, Germany Saturday, March 29, 202 ...
Pharmabiz1d
4Moving Biotech gets Health Canada approval to initiate phase 2a INFLAM MOTION clinical trial for knee osteoarthritis
Moving Biotech gets Health Canada approval to initiate phase 2a INFLAM MOTION clinical trial for knee osteoarthritis: Lille & Paris, France Saturday, March 29, 2025, 17:00 Hrs [I ...
Pharmabiz1d
Bayer, Puhe BioPharma ink global license pact to develop, manufacture and commercialize the MTA-cooperative PRMT5 inhibitor
Bayer, Puhe BioPharma ink global license pact to develop, manufacture and commercialize the MTA-cooperative PRMT5 inhibitor: Berlin, Germany Saturday, March 29, 2025, 12:00 Hrs [I ...
Pharmabiz1d
US FDA approves Soleno Therapeutics’ Vykat XR to treat hyperphagia in Prader-Willi syndrome
US FDA approves Soleno Therapeutics’ Vykat XR to treat hyperphagia in Prader-Willi syndrome: Redwood City, California Saturday, March 29, 2025, 18:00 Hrs [IST] Soleno Therapeuti ...
Pharmabiz1d
CDSCO declares a total of 103 drug samples as NSQ in February
CDSCO declares a total of 103 drug samples as NSQ in February: Our Bureau, New Delhi Saturday, March 29, 2025, 13:30 Hrs [IST] The Central Drugs Standard Control Organisation (CDS ...